Imunon, Inc. (NASDAQ:IMNN) Q2 2023 Earnings Call Transcript

Page 4 of 4

Corinne Le Goff: Thank you very much. So as you know, we have been using the phrase ‘banking of the future’ to describe our work, and this is exactly what our vision is, is to be the provider of safe and effective vaccines that are superior to current vaccines in terms of durability and buffer protection, that are stable at workable temperatures, that can be manufactured rapidly to respond to evolving pathogens, and offer better compliance for maximization, with no need for a device or virus. We also believe our technology owns excellent promise in immuno-oncology. So we look forward to keeping you informed of our progress for joining us, and we look forward to speaking with you again at our upcoming R&D Day event. Have a very nice day.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Imunon Inc. (NASDAQ:IMNN)

Page 4 of 4